AU6861796A - Angiotensin iv and analogs as regulators of fibrinolysis - Google Patents

Angiotensin iv and analogs as regulators of fibrinolysis

Info

Publication number
AU6861796A
AU6861796A AU68617/96A AU6861796A AU6861796A AU 6861796 A AU6861796 A AU 6861796A AU 68617/96 A AU68617/96 A AU 68617/96A AU 6861796 A AU6861796 A AU 6861796A AU 6861796 A AU6861796 A AU 6861796A
Authority
AU
Australia
Prior art keywords
fibrinolysis
angiotensin
regulators
analogs
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU68617/96A
Inventor
Joseph W Harding
Douglas E. Vaughan
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Brigham and Womens Hospital Inc
Washington State University Research Foundation
Original Assignee
University of Washington
Brigham and Womens Hospital Inc
Washington State University Research Foundation
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University of Washington, Brigham and Womens Hospital Inc, Washington State University Research Foundation filed Critical University of Washington
Publication of AU6861796A publication Critical patent/AU6861796A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/08—Tripeptides
    • C07K5/0821—Tripeptides with the first amino acid being heterocyclic, e.g. His, Pro, Trp
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/08—Peptides having 5 to 11 amino acids
    • A61K38/085—Angiotensins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/55—Protease inhibitors
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/26—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against hormones ; against hormone releasing or inhibiting factors
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/08—Tripeptides
    • C07K5/0802—Tripeptides with the first amino acid being neutral
    • C07K5/0804—Tripeptides with the first amino acid being neutral and aliphatic
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/14—Angiotensins: Related peptides
AU68617/96A 1995-10-30 1996-08-27 Angiotensin iv and analogs as regulators of fibrinolysis Abandoned AU6861796A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US55017495A 1995-10-30 1995-10-30
US550174 1995-10-30
PCT/US1996/013804 WO1997016201A1 (en) 1995-10-30 1996-08-27 Angiotensin iv and analogs as regulators of fibrinolysis

Publications (1)

Publication Number Publication Date
AU6861796A true AU6861796A (en) 1997-05-22

Family

ID=24196053

Family Applications (1)

Application Number Title Priority Date Filing Date
AU68617/96A Abandoned AU6861796A (en) 1995-10-30 1996-08-27 Angiotensin iv and analogs as regulators of fibrinolysis

Country Status (2)

Country Link
AU (1) AU6861796A (en)
WO (1) WO1997016201A1 (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU6317996A (en) * 1995-07-07 1997-02-10 Sagami Chemical Research Center Peptide derivatives and angiotensin iv receptor agonist
US7378489B1 (en) 1999-12-23 2008-05-27 Protherics Medicines Development Limited Angiotensin derivatives
WO1999053955A1 (en) * 1998-04-22 1999-10-28 Desmos, Inc. Creation of bioactive surfaces through selective adsorption
FR2915392A1 (en) * 2007-04-27 2008-10-31 Univ Claude Bernard Lyon I Eta Use of an antagonist of angiotensin IV e.g. peptide compound, for the preparation of a drug to treat or prevent Type II diabetes, insulin resistance or cardiovascular risk of metabolic syndrome

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0647239A4 (en) * 1992-06-24 1997-07-02 Univ Washington Angiotensin iv peptides and receptor.

Also Published As

Publication number Publication date
WO1997016201A1 (en) 1997-05-09

Similar Documents

Publication Publication Date Title
AU6625896A (en) Oxygen bandage
AU7364896A (en) Treatment of pruritus with vitamin d and analogs thereof
AU5893696A (en) Modification of polypeptides
AU7331796A (en) Knapsack
AUPN344195A0 (en) Monitoring of oro-nasal respiration
AU3809795A (en) Genetic control of flowering
AU3019795A (en) Oxygen respirator
AU6355096A (en) Sulphonamides as herbicides and plant-growth regulators
AU5309996A (en) Gas pressure regulator
AU1372897A (en) 2-amino-heterocycles and therapeutic uses therefor
AUPN250795A0 (en) Stress regulator
AU5893796A (en) Modification of polypeptides
GB9512290D0 (en) Uses of polyhexanide
AU7497798A (en) 3-epi compounds of vitamin d3 and uses thereof
AU6517396A (en) Preparation of N-substituted 3-hydroxypyrazoles
AU5381696A (en) Synthesis of bis-indolylmaleimides
AU3217595A (en) Stabilized compositions containing hemoglobin
AU4940296A (en) Genetic modification of plants
AU6934896A (en) Use of multi-block copolymers as thermo-thickeners
AU4224096A (en) Use of phenylcyclohexylcarboxamides
AU5405496A (en) Manufacture of bags
AU6861796A (en) Angiotensin iv and analogs as regulators of fibrinolysis
AU1278897A (en) Passification of zinc surfaces
AU6015196A (en) Voltage regulator
AUPN131095A0 (en) Novel bacteriocin JG 126